Posts Tagged: cancer

Tcell_WBC_SingleCell_BLUE_BG_580x200

The PD1 race picks up pace

If you’ve been following developments in cancer immunotherapy closely, you’ve probably heard of programmed death 1 (PD1/PDCD1, also known as CD279) and PDL1 (CD274). Their interaction is at the center of new immune checkpoint-targeting therapies coming out of the pharmaceutical industry, such as Bristol-Myers Squibb’s nivolumab and Merck’s pembrolizumab (1, 5). What are PD1 and PDL1, and… Read article →



Biogenesis

Back to the beginning: microRNA biogenesis

Introduction Since the discovery of microRNA (miRNA) in the early 1990s, much effort has been devoted to understanding how miRNAs are produced in the cell and how genes are controlled by these tiny RNAs. In today’s blog, we look back to the very beginning of miRNA discovery, and discuss miRNA biogenesis and its influence in cancer… Read article →


miRNA_RISC_Ribosomes_700x233

Emerging roles of competing endogenous RNA (ceRNA)

If you have been following our blog posts about microRNA (miRNA) – or if you have been studying the microRNA world – you are likely familiar with the small 22-nucleotide RNAs that target messenger RNAs (mRNAs) to repress their translation into protein. The ceRNA hypothesis In 2011, Pier Paolo Pandolfi research lab proposed the hypothesis… Read article →


10TopCTCsFAQs_700x233

Top 10 FAQs on circulating tumor cells

During the past 20 years, the interest in circulating tumor cells (CTCs) has increased dramatically due to their potential as circulating biomarkers in monitoring cancer progression and treatment. However, selecting and detecting CTCs from whole blood of cancer patients in the background of normal cells is very challenging. Since last summer, Dr. Siegfried Hauch, Director… Read article →